DAFNA Capital Management’s Windtree Therapeutics Inc WINT Stock Holding History

DAFNA Capital Management’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-480,833	Closed	-$1.23M	–	81
2016 Q3	$1.23M	Sell	480,833 -52,525	-10%	-$114K	0.86%	39
2016 Q2	$1.03M	Hold	533,358	–	–	0.82%	43
2016 Q1	$891K	Sell	533,358 -1	-0%	-$2	0.77%	40
2015 Q4	$1.6M	Sell	533,359 -2,966	-0.6%	-$12.2K	1.42%	24
2015 Q3	$2.25M	Buy	536,325 +193,834	+57%	+$1.28M	2.24%	12
2015 Q2	$3.26M	Sell	342,491 -2,500	-0.7%	-$35.1K	2.76%	9
2015 Q1	$5.75M	Sell	344,991 -62,062	-15%	-$1.22M	4.41%	5
2014 Q4	$6.61M	Hold	407,053	–	–	5.23%	5
2014 Q3	$10.5M	Hold	407,053	–	–	10.58%	2
2014 Q2	$10.1M	Hold	407,053	–	–	9.61%	4
2014 Q1	$12.3M	Hold	407,053	–	–	10.53%	1
2013 Q4	$12.8M	Buy	407,053 +262,364	+181%	+$8.21M	13.2%	1
2013 Q3	$3.97M	Buy	144,689 +20,856	+17%	+$506K	4.34%	8
2013 Q2	$2.63M	Buy	+123,833	New	+$3.05M	3.86%	9

Other funds holding WINT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

DAFNA Capital Management's WINT Position: Q4 2016 in Review

DAFNA Capital Management sold out of Windtree Therapeutics Inc (WINT) in Q4 2016, closing a stake of 480,833 shares — an estimated $1.23M sold.

DAFNA Capital Management first reported a position in WINT in Q2 2013 and held it in 14 quarters. The position peaked at $12.8M in Q4 2013. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.

DAFNA Capital Management reported no remaining Windtree Therapeutics Inc position as of Q4 2016 after selling out during the quarter.
DAFNA Capital Management sold 480,833 Windtree Therapeutics Inc shares in Q4 2016, an estimated $1.23M.
DAFNA Capital Management first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 14 quarters.
DAFNA Capital Management's Windtree Therapeutics Inc position peaked at $12.8M in Q4 2013.
31 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2016.

Based on DAFNA Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.